Title (A211201) Change in Mammographic Density with Metformin Use: A Companion Study to NCIC Study MA.32
Principal Investigator Ermelinda Bonaccio, MD
Study Number 229312
Summary To evaluate the change in percent mammographic density in contralateral (unaffected breast) from prior to the initiation of metformin or placebo treatment through one year of therapy in patients with hormone receptor negative breast cancer.
Eligibility Please see Clinicaltrials.gov link for current Eligibility criteria.